Hepatitis B vaccine - GenPhar

Drug Profile

Hepatitis B vaccine - GenPhar

Latest Information Update: 07 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GenPhar
  • Class Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • No development reported Hepatitis B

Most Recent Events

  • 21 Mar 2007 GenPhar's Hepatitis B vaccine is available for licensing (www.genphar.com)
  • 21 Mar 2007 Phase-I clinical trials in Hepatitis B in USA (Parenteral)
  • 18 Apr 2002 Preclinical trials in Hepatitis B in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top